Table 4.
Results from GSEA for breast cancer in FF samples. The following 26 gene sets (GO-terms) were common in all the four lists shown in figure-4(v)
| Gene Set Description | # of Genes | ES* | NES** | p-value |
|---|---|---|---|---|
| metalloexopeptidase activity | 37 | 0.5273 | 1.6927 | 0.0000 |
| transforming growth factor beta receptor signaling pathway | 67 | 0.4600 | 1.6388 | 0.0192 |
| fatty acid metabolic process | 116 | 0.3829 | 1.5961 | 0.0000 |
| sterol transport | 26 | 0.4747 | 1.5879 | 0.0417 |
| cholesterol transport | 25 | 0.4770 | 1.5853 | 0.0208 |
| vitamin metabolic process | 22 | 0.5190 | 1.5649 | 0.0204 |
| regulation of insulin secretion | 26 | 0.4652 | 1.5559 | 0.0000 |
| regulation of biomineral formation | 26 | 0.4641 | 1.5288 | 0.0000 |
| muscle cell differentiation | 40 | 0.4888 | 1.5192 | 0.0408 |
| vitamin binding | 121 | 0.3420 | 1.4857 | 0.0385 |
| regulation of blood vessel size | 43 | 0.4805 | 1.4810 | 0.0408 |
| regulation of tube size | 43 | 0.4805 | 1.4810 | 0.0408 |
| BMP signaling pathway | 36 | 0.5195 | 1.4783 | 0.0426 |
| regulation of cell proliferation | 171 | 0.3540 | 1.4709 | 0.0200 |
| glucose metabolic process | 42 | 0.3829 | 1.4667 | 0.0217 |
| blood circulation | 46 | 0.4345 | 1.4544 | 0.0204 |
| branching morphogenesis of a tube | 55 | 0.4291 | 1.4160 | 0.0208 |
| regulation of hormone secretion | 36 | 0.3898 | 1.4101 | 0.0385 |
| magnesium ion binding | 418 | 0.2887 | 1.3951 | 0.0000 |
| GTPase binding | 85 | 0.3092 | 1.3766 | 0.0000 |
| response to drug | 81 | 0.3105 | 1.3461 | 0.0364 |
| carbohydrate binding | 301 | 0.2844 | 1.3073 | 0.0204 |
| small GTPase binding | 80 | 0.2944 | 1.2867 | 0.0364 |
| protein dimerization activity | 433 | 0.2449 | 1.2408 | 0.0196 |
| negative regulation of DNA metabolic process | 23 | -0.4876 | -1.5264 | 0.0217 |
| nucleosome | 87 | -0.6222 | -1.5847 | 0.0417 |
*ES: Enrichment score, **NES: normalized enrichment score